Microbot Medical Inc. reported that the first phase of the previously announced collaboration with Corewell Health has been completed, which demonstrated the LIBERTY System's technical capabilities and outlines potential future applications in a range of endovascular interventions. The objective of the collaboration, which will take place in multiple phases, is to enable telerobotics between remote centers by utilizing the LIBERTY System. The agreement with Corewell Health includes the right to mutually evaluate the LIBERTY System for remote procedures and it is being led by Ryan Madder, M.D., Section Chief of Interventional Cardiology and Director of the Cardiac Cath Lab at Corewell Health in Grand Rapids, Michigan.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9301 USD | -1.99% | +2.15% | -43.29% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-43.29% | 13.39M | |
+29.77% | 49.46B | |
+1.00% | 42.58B | |
+49.56% | 42.49B | |
-5.26% | 29.09B | |
+13.68% | 26.61B | |
-22.99% | 18.64B | |
+8.22% | 13.16B | |
+32.41% | 12.55B | |
+24.01% | 12.1B |
- Stock Market
- Equities
- MBOT Stock
- News Microbot Medical Inc.
- Microbot Medical Announces Positive Results from the First Phase of Its Collaboration with Corewell Health